Abstracts tagged "lupus nephritis and transplantation"

Abstract Number: 711 • 2018 ACR/ARHP Annual Meeting
Recurrence of Lupus Nephritis in Renal Transplant Recipients
Debendra Pattanaik¹, Joseph Green², Manish Talwar³, Miklos Molnar³ and Syed Hasan Raza¹, ¹Rheumatology, University of Tennessee Health Science Center, Memphis, TN, ²rheumatology, University of Tennessee Health Science Center, memphis, TN, ³University of Tennessee Health Science Center, Memphis, TN
Background/Purpose: Recurrence of lupus nephritis in the graft is a concern in lupus patients with end stage renal disease who undergo renal transplantation. The recurrence…
Abstract Number: 607 • 2012 ACR/ARHP Annual Meeting
Activity Index After Renal Failure in a Cohort of 32 Patients with Lupus Nephritis
Cristina Gonzalez-Pulido¹, Sara Croca² and D.A. Isenberg³, ¹Internal Medicine, University Hospital Virgen del Rocio, Seville, Spain, ²Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, ³Centre for Rheumatology Research, University College London, London, United Kingdom
Background/Purpose: Most published studies that have measured activity in patients with lupus nephritis suggest the disease is relatively quiescent after renal failure. Purpose: To analyze…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].